Stockreport

Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis [Yahoo! Finance]

Cognition Therapeutics, Inc.  (CGTX) 
PDF Cognition Therapeutics, Inc. We believe regulatory strategy expedites development of potential first treatment to address DLB psychosis PURCHASE, N.Y., March 02, 20 [Read more]